Saint Kitts and Nevis vs Vanuatu: The number of people with susceptibility test result for rifampicin
Saint Kitts and Nevis
0
in 2021
Vanuatu
0
in 2021
Saint Kitts and Nevis rank
146th
Vanuatu rank
146th
The number of people with susceptibility test result for rifampicin over time
- Saint Kitts and Nevis
- Vanuatu
How they compare
Saint Kitts and Nevis currently reports 0 against 0 in Vanuatu, a difference of 0.
Across all 5 years both countries report, Vanuatu has been ahead every year.
Saint Kitts and Nevis ranks 146th and Vanuatu ranks 146th of 155 countries.
Vanuatu has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Saint Kitts and Nevis | Vanuatu | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1 | 46.33 | 45.33 | Vanuatu |
| 2020s | 0.5 | 21.5 | 21 | Vanuatu |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Saint Kitts and Nevis or Vanuatu?
- Saint Kitts and Nevis, at 0 against 0 in Vanuatu as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Saint Kitts and Nevis and Vanuatu?
- 0, with Saint Kitts and Nevis ahead.
- How many years of comparable data are there for Saint Kitts and Nevis and Vanuatu?
- 5 years are reported by both, from 2017 to 2021.
- How do Saint Kitts and Nevis and Vanuatu rank globally for the number of people with susceptibility test result for rifampicin?
- Saint Kitts and Nevis ranks 146th and Vanuatu ranks 146th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.